Gracivask

Gracivask

amlodipine

Manufacturer:

Gracia Pharmindo
Concise Prescribing Info
Contents
Amlodipine besylate
Indications/Uses
HTN. Myocardial ischemia.
Dosage/Direction for Use
HTN Initially 5 mg once daily. Max: 10 mg. Patient w/ low body wt, debility, renal insufficiency, elderly Initially 2.5 mg once daily. Stable or vasospastic angina 5-10 mg daily.
Administration
May be taken with or without food.
Contraindications
Sensitivity to dihydropyridine.
Special Precautions
Kidney failure, liver dysfunction. Pregnancy & lactation. Childn.
Adverse Reactions
Headache, edema, fatigue, somnolence, nausea, abdominal pain, skin redness, tachycardia, dizziness; itching, skin rash, dyspnea, dyspepsia, asthenia, myalgia, gingival hyperplasia, erythema multiforme. Rarely, MI, arrhythmia (ventricular tachycardia & atrial fibrillation) & chest pain.
MIMS Class
Calcium Antagonists
ATC Classification
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Gracivask tab 10 mg
Packing/Price
3 × 10's (Rp255,000/boks)
Form
Gracivask tab 5 mg
Packing/Price
3 × 10's (Rp135,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in